Advertisement

Topics

PubMed Journals Articles About "New England Anti-Vivisection Society" RSS

20:29 EST 17th December 2017 | BioPortfolio

New England Anti-Vivisection Society PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest New England Anti-Vivisection Society articles that have been published worldwide.

More Information about "New England Anti-Vivisection Society" on BioPortfolio

We have published hundreds of New England Anti-Vivisection Society news stories on BioPortfolio along with dozens of New England Anti-Vivisection Society Clinical Trials and PubMed Articles about New England Anti-Vivisection Society for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of New England Anti-Vivisection Society Companies in our database. You can also find out about relevant New England Anti-Vivisection Society Drugs and Medications on this site too.

Showing "England Anti Vivisection Society" PubMed Articles 1–25 of 21,000+

In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?

The advent of anti-programmed death receptor-1/ligand-1 antibodies (anti-PD(L)1) is profoundly changing the therapeutic strategy of oncology. As anti-PD(L)1 modulate tumour microenvironment, it might impact sensitivity to conventional cancer therapy (CCT). Therefore, we explored whether sensitivity to CCT was different before and after anti-PD(L)1 therapy.


The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population.

Higher circulating omega-3 fatty acids (n-3 FAs) are associated with a lower prevalence of anti-CCP antibodies and RF in subjects without RA. We examined whether, in anti-CCP+ subjects, n-3 FAs also play a role in development of inflammatory arthritis (IA).

Continuing Anti-thrombotic Medication During Low-to-Intermediate Risk Spinal Procedures: A Retrospective Evaluation.

The current American Society of Regional Anesthesia (ASRA) guidelines recommend discontinuing anti-thrombotic therapy prior to any interventional spine procedures to decrease the incidence of bleeding complications. However, discontinuing anti-thrombotics may pose considerable danger in terms of cerebrovascular and cardiovascular events. Recent evidence suggests that some spinal interventions may still be performed safely with anti-thrombotics on board and some practitioners thus elect to continue certain a...


Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis.

Recent studies suggest that anti-inflammatory medication may play a role in the treatment of mood disorders.

Effects of female sex hormones on folic acid-induced anti-angiogenesis.

Pregnant women have been recommended to take FA daily to prevent birth defects in the brain and spinal cord. We previously showed that folic acid (FA) exerts an anti-angiogenic activity. Since angiogenesis is important for endometrial reorganization and embryonic development, there should be some mechanisms to allow the pregnant mother and the fetus to escape from the FA-induced anti-angiogenesis. The present study was designed to investigate the effect of female sex hormones on the FA-induced anti-angiogen...

Is Pre-transplant sensitization against Angiotensin II Type1 Receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti HLA Luminex era?

We aimed to assess the correlation of anti-angiotensin II type 1 receptor antibodies (anti-AT1R-Abs) before transplantation on a multicentric cohort of kidney transplant recipients (2008-2012), under Tacrolimus and Mycofenolate mofetil (MMF), screened by Luminex technology for anti -HLA immunization.

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies.

Rituximab is a chimeric monoclonal anti-CD20 B-cell-depleting antibody increasingly used off-label in multiple sclerosis (MS). The clinical relevance of anti-drug antibodies (ADAs) against rituximab in MS is unknown.

Anti-TIF1-γ autoantibodies-positive dermatomyositis: where is the malignancy?

Comment on 'Licence to save: a UK survey of anti-VEGF use for the eye in 2015'.

The European politics of animal experimentation: From Victorian Britain to 'Stop Vivisection'.

This paper identifies a common political struggle behind debates on the validity and permissibility of animal experimentation, through an analysis of two recent European case studies: the Italian implementation of the European Directive 2010/63/EC regulating the use of animals in science, and the recent European Citizens' Initiative (ECI) 'Stop Vivisection'. Drawing from a historical parallel with Victorian antivivisectionism, we highlight important threads in our case studies that mark the often neglected ...

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

Combined CTLA-4 and PD-1 blockade induces high rates of immune-related adverse events (irAEs). The safety of resuming anti-PD-1 in patients who discontinue combination therapy due to irAEs is not known.

More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.

More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.

Recent Progress in Anti-HIV Broadly Neutralizing Antibody Research.

Moving Upstream - Anti-TSLP in Persistent Uncontrolled Asthma.

Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.

Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.

Congenital heart block (CHB) develops in 1-2% of anti-Ro/SSA-positive pregnancies and has a recurrence rate of 12-20%, which indicates that factors other than maternal autoantibodies are crucial for CHB to occur. Here, we aimed to evaluate the influence of factors previously associated with CHB on the occurrence of milder forms of fetal cardiac conduction disturbances, shown to occur in up to 30% of anti-Ro/SSA-positive pregnancies, and on neonatal outcome in a large cohort of prospectively followed pregnan...

Autoimmune Diabetes Presented with Diabetic Ketoacidosis Induced by Immunotherapy in an Adult with Melanoma.

Immunotherapy has been approved for treatment of melanoma. Autoimmune endocrinopathies have been reported in trials involving immunotherapy but autoimmune diabetes has not been definitively linked to them. Here we describe a case of autoimmune diabetes presenting with DKA after receiving combined immunotherapy with anti-CTLA4 and anti-PD1 monoclonal antibodies.

Vestibular Schwannoma Growth With Aspirin and Other Nonsteroidal Anti-inflammatory Drugs.

To investigate whether the use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) impact the growth of vestibular schwannoma (VS).

Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome.

Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.

Anti-NXP2 antibody-associated extensive subcutaneous calcinosis in adult-onset myositis.

Anti-infective Acquisition Costs for a Stewardship Program: Getting to the Bottom Line.

Though antimicrobial stewardship programs (ASPs) are in place for patient safety, financial justification is often required. In 2016, the Infectious Diseases Society of America (IDSA) recommended that anti-infective costs be measured by patient-level administration data normalized for patient census. Few publications use this methodology. Here, we aim to compare 3 methods of drug cost analysis during 3 phases of an ASP as an example of this recommendation's implementation.

BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.

Immune-related bone marrow failure following anti-PD1 therapy.


Quick Search
Advertisement